BCL2A1 抗体
BCL2A1 适用: 人 WB, ELISA, IF, ICC 宿主: 兔 Polyclonal unconjugated
BCL2A1 抗体 by Grade
Find BCL2A1 抗体 with a specific Grade. The Grade listed below are among those available. Click on a link to go to the corresponding products.
BCL2A1 抗体 by 适用
Find BCL2A1 抗体 for a variety of species such as anti-Human BCL2A1, anti-Mouse BCL2A1, anti-Rat BCL2A1. The species listed below are among those available. Click on a link to go to the corresponding products.
BCL2A1 抗体 by 应用范围
Find BCL2A1 抗体 validated for a specific application such as WB, ELISA, IHC, IHC (p). Some of the available applications are listed below. Click on a link to go to the corresponding products.
BCL2A1 抗体 by 抗体来源
Find BCL2A1 抗体 with a specific 抗体来源. The 抗体来源 listed below are among those available. Click on a link to go to the corresponding products.
BCL2A1 抗体 by 克隆形成能力
Find available monoclonal or polyclonal BCL2A1 抗体. Click on a link to go to the corresponding products.
BCL2A1 抗体 by 克隆
Find BCL2A1 抗体 with a specific 克隆. The 克隆 listed below are among those available. Click on a link to go to the corresponding products.
BCL2A1 抗体 by 标记
Find BCL2A1 抗体 with a specific conjugate such as Biotin, FITC, Alexa Fluor 488. The conjugates listed below are among those available. Click on a link to go to the corresponding products.
Popular BCL2A1 抗体
- (2)
- (2)
- (2)
- (1)
- (2)
- (3)
- (3)
- (1)
- (1)
- (1)
- (1)
- (2)
- (2)
- (2)
Latest Publications for our BCL2A1 抗体
: "Dandelion root extract affects colorectal cancer proliferation and survival through the activation of multiple death signalling pathways." in: Oncotarget, Vol. 7, Issue 45, pp. 73080-73100, (2016) (PubMed).: "Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways." in: Journal of hepatology, Vol. 51, Issue 1, pp. 139-48, (2009) (PubMed).
: "Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity." in: Occupational and environmental medicine, Vol. 66, Issue 12, pp. 848-53, (2009) (PubMed).
: "Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years." in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, Vol. 14, Issue 4, pp. 460-8, (2007) (PubMed).
: "Weight loss reduces adipose tissue cathepsin S and its circulating levels in morbidly obese women." in: The Journal of clinical endocrinology and metabolism, Vol. 91, Issue 3, pp. 1042-7, (2006) (PubMed).
: "Gene expression changes and signaling events associated with the direct antimelanoma effect of IFN-gamma." in: Cancer research, Vol. 65, Issue 19, pp. 8869-77, (2005) (PubMed).
: "Up-regulation of Bfl-1/A1 via NF-kappaB activation in cisplatin-resistant human bladder cancer cell line." in: Cancer letters, Vol. 212, Issue 1, pp. 61-70, (2004) (PubMed).
: "Cell death in the third millennium." in: Cell death and differentiation, Vol. 7, Issue 1, pp. 2-7, (2000) (PubMed).
: "Structural basis of BFL-1 for its interaction with BAX and its anti-apoptotic action in mammalian and yeast cells." in: The Journal of biological chemistry, Vol. 275, Issue 15, pp. 11092-9, (2000) (PubMed).
: "A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow." in: Oncogene, Vol. 11, Issue 9, pp. 1693-8, (1995) (PubMed).
Aliases for BCL2A1 抗体
BCL2 related protein A1 (BCL2A1) 抗体BCL2-related protein A1 (Bcl2a1) 抗体
BCL2-related protein A1 (BCL2A1) 抗体
ACC-1 抗体
ACC-2 抗体
BCL2A1 抗体
Bcl2a1d 抗体
BCL2L5 抗体
BFL1 抗体
GRS 抗体
HBPA1 抗体
